Neuroncell™, bone marrow-derived mesenchymal stem cells for middle cerebral artery infarct
This study aims to determine the efficacy of intravenous transplantation of autologous bone marrow-derived mesenchymal stem cells in patients with acute middle cerebral artery infarct.
Read More
Product Information for
Neuroncell™, bone marrow-derived mesenchymal stem cells for middle cerebral artery infarct